I appreciated your original post actually!
In my eyes (rose colour) the results of the study weren't doom and gloom at all. What's available to us in the text raises more questions than answers but I'm satisfied at this point in time Cardiocel is an effective substitute for diseased native tissue. The response WP gave to Waz, whilst not verified, I do not doubt and is plausible.
Long live Admedus!
oral presentation- ADAPT in AV reconstruction in CHD, page-54
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.150(1.48%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.26 | $10.35 | $9.80 | $295.8K | 29.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22 | $9.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 2758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |